Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001628280-23-020037
Filing Date
2023-05-30
Accepted
2023-05-30 10:07:49
Documents
8
Period of Report
2023-05-30

Document Format Files

Seq Description Document Type Size
1 6-K a230530_6kxmorxvotingright.htm 6-K 12073
2 EX-99.1 a230530_exhibit991.htm EX-99.1 2083
3 GRAPHIC a230530_exhibit991001.jpg GRAPHIC 111480
4 GRAPHIC a230530_exhibit991002.jpg GRAPHIC 103889
5 GRAPHIC a230530_exhibit991003.jpg GRAPHIC 102286
6 GRAPHIC a230530_exhibit991004.jpg GRAPHIC 103694
7 GRAPHIC a230530_exhibit991005.jpg GRAPHIC 82966
8 GRAPHIC a230530_exhibit991006.jpg GRAPHIC 29900
  Complete submission text file 0001628280-23-020037.txt   751367
Mailing Address SEMMELWEISSTR. 7 PLANEGG 2M 82152
Business Address SEMMELWEISSTR. 7 PLANEGG 2M 82152 49 89 89927-0
MorphoSys AG (Filer) CIK: 0001340243 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38455 | Film No.: 23972089
SIC: 2834 Pharmaceutical Preparations